Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
Details for Australian Patent Application No. 2001267887 (hide)
International Classifications
Event Publications
27 November 2003 Assignment before Grant
Suntory Limited The application has been assigned to Daiichi Suntory Pharma Co Ltd
8 January 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from Daiichi Suntory Pharma Co Ltd to Daiichi Suntory Pharma Co., Ltd.
12 January 2006 Change of Name(s) of Applicant(s), Section 104
Daiichi Suntory Pharma Co., Ltd. The name of the applicant has been changed to Daiichi Asubio Pharma Co., Ltd
15 February 2007 Application Accepted
Published as AU-B-2001267887
24 May 2007 Change of Name(s) of Applicant(s), Section 104
Daiichi Asubio Pharma Co., Ltd The name of the applicant has been changed to Asubio Pharma Co., Ltd
14 June 2007 Standard Patent Sealed
30 August 2007 Change of Name(s) of Applicant(s), Section 104
Asubio Pharma Co., Ltd The name of the applicant has been changed to Asubio Pharma Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser